The Latest Breaking News from FDA

Confused by sunscreen terminology? Here is everything you need to know to understand sunscreen labels.

Ozempic face is one of the most famous reported side effects of the injectable. Here, three doctors reveal what you need to know about it

The U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective

In the past five years, several new drugs have been brought to market that could lead to a profound, if not revolutionary, change in how health care providers – and the public – view weight loss.

Officials are trying to clamp down on the illicit supply of xylazine, a veterinary drug sold online.

Neuralink is making a Class III medical device known as a brain-computer interface. The device connects the brain to an external computer via a Bluetooth signal, enabling continuous communication back and forth. It could revolutionise treatment for conditions such as Parkinson’s disease, epilepsy, and spinal cord injuries.

Musk has made many radical claims regarding his future vision for the technology. What comes after FDA approval?

A more flexible model of oversight avoids hyper-cautious top-down regulation and enables swifter access to the substantial benefits of safe A.I.

The firm has developed a tool that can help faster and simpler diagnosis of diseases such as Parkinson's

Type 1 diabetes affects 46.3 million individuals globally, with an annual rise of roughly 3 per cent. Read further on Dynamite News:

April’s robust labor market and persistently high inflation could strengthen the likelihood of interest rates remaining elevated for an extended period. So, fundamentally strong value stocks CIRCOR International (CIR), Consolidated Water (CWCO), and Cidara Therapeutics (CDTX), which have generated solid returns, could be one’s top picks now. Keep reading.